Format

Send to

Choose Destination
J Natl Compr Canc Netw. 2019 Oct 1;17(10):1154-1165. doi: 10.6004/jnccn.2019.0049.

NCCN Guidelines Insights: Multiple Myeloma, Version 1.2020.

Author information

1
1Mayo Clinic Cancer Center.
2
2University of Wisconsin Carbone Cancer Center.
3
3Roswell Park Comprehensive Cancer Center.
4
4Stanford Cancer Institute.
5
5Fred & Pamela Buffett Cancer Center.
6
6University of Michigan Rogel Cancer Center.
7
7Dana-Farber/Brigham and Women's Cancer Center.
8
8St. Jude Children's Research Hospital/The University of Tennessee Health Science Center.
9
9Vanderbilt-Ingram Cancer Center.
10
10UC San Diego Moores Cancer Center.
11
11The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute.
12
12Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute.
13
13Abramson Cancer Center at the University of Pennsylvania.
14
14O'Neal Comprehensive Cancer Center at UAB.
15
15Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance.
16
16City of Hope National Medical Center.
17
17The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
18
18Duke Cancer Institute.
19
19Memorial Sloan Kettering Cancer Center.
20
20UCSF Helen Diller Family Comprehensive Cancer Center.
21
21Patient Advocate.
22
22Massachusetts General Hospital Cancer Center.
23
23Huntsman Cancer Institute at the University of Utah.
24
24Robert H. Lurie Comprehensive Cancer Center of Northwestern University.
25
25Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine.
26
26Fox Chase Cancer Center.
27
27The University of Texas MD Anderson Cancer Center; and.
28
28National Comprehensive Cancer Network.

Abstract

The NCCN Guidelines for Multiple Myeloma provide recommendations for diagnosis, workup, treatment, follow-up, and supportive care for patients with monoclonal gammopathy of renal significance, solitary plasmacytoma, smoldering myeloma, and multiple myeloma. These NCCN Guidelines Insights highlight some of the important updates and changes in the 1.2020 version of the NCCN Guidelines for Multiple Myeloma.

PMID:
31590151
DOI:
10.6004/jnccn.2019.0049

Supplemental Content

Full text links

Icon for Sheridan PubFactory
Loading ...
Support Center